N4 Pharma (LON:N4P) Shares Down 11.1%

N4 Pharma Plc (LON:N4PGet Free Report)’s stock price fell 11.1% on Wednesday . The stock traded as low as GBX 0.60 ($0.01) and last traded at GBX 0.60 ($0.01). 232,845 shares changed hands during trading, a decline of 79% from the average session volume of 1,087,097 shares. The stock had previously closed at GBX 0.68 ($0.01).

N4 Pharma Stock Up 1.4 %

The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 14.86. The company has a fifty day moving average of GBX 0.75 and a two-hundred day moving average of GBX 0.81. The company has a market cap of £1.77 million, a PE ratio of -65.00 and a beta of -0.07.

N4 Pharma Company Profile

(Get Free Report)

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.